JKA3 inhibitor 31
CAS No. 1637749-82-6
JKA3 inhibitor 31( —— )
Catalog No. M12470 CAS No. 1637749-82-6
JKA3 inhibitor 31 is a highly potent, selective, reversible, covalent JAK3 inhibitor with IC50 of 49 nM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameJKA3 inhibitor 31
-
NoteResearch use only, not for human use.
-
Brief DescriptionJKA3 inhibitor 31 is a highly potent, selective, reversible, covalent JAK3 inhibitor with IC50 of 49 nM.
-
DescriptionJKA3 inhibitor 31 is a highly potent, selective, reversible, covalent JAK3 inhibitor with IC50 of 49 nM, shows no activity against other JAK kinases; also inhibits BLK, ERB-B4 and ITK with IC50 of 22 nM, 44 nM and 221 nM, respectively.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayAngiogenesis
-
TargetJAK
-
RecptorJAK
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1637749-82-6
-
Formula Weight288.31
-
Molecular FormulaC17H12N4O
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical Name3-(3-(1H-indazol-4-yl)phenyl)-2-cyanoacrylamide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. London N, et al. Nat Chem Biol. 2014 Dec;10(12):1066-72.
2. Clark JD, et al. J Med Chem. 2014 Jun 26;57(12):5023-38.
molnova catalog
related products
-
LY2784544
LY2784544 (Gandotinib) is a potent, selective and ATP-competitive inhibitor of JAK2V617F.
-
JAK3-IN-2
A potent and highly selective JAK3 inhibitor with IC50 of 0.15 nM.
-
EP009
A selective, orally active JAK3 inhibitor that reduces IL-2-mediated JAK3 tyrosine phosphorylation with cellular IC50 of 10-20 uM.
Cart
sales@molnova.com